Applied
use of venovenous extracorporeal membrane oxygenation support
insevere
septic shock andsepsis
induced cardiomyopathywithunknownetiology
pneumonia: a case
report
Fengyuan
Li1a,
Lin
Yang1a, Jiahao Chen1a, Qiang
Guo1b
a These authors contributed equally to this
work.
b Corresponding author
1Department of Medicine, Respiratory, Emergency and
Intensive Care Medicine, The First Affiliated Hospital of Soochow
University, Suzhou, China 215006
Running title: Applied use of V-V ECMO in septic shock and associated
septic cardiomyopathy with unknown etiology pneumonia
Address Correspondence to:
Qiang Guo, M.D. Ph.D.
Department of Medicine, Respiratory, Emergency and Intensive Care
Medicine, The First Affiliated Hospital of Soochow University
188 Shizhi st
Suzhou, China 215006
E-mail: dr_qiangguo@163.com
ABSTRACT
BACKGROUD: There is no consensus over the effect of V-V ECMO on
septic patients with sepsis-induced cardiomyopathy.
CASE PRESENTATION:A
48-year-old male was transferred to our emergency department for
acute-onset fever lasting for four days on November 1, 2019. He traveled
in many places in northern China (Yan’an, Beijing, Qinhuangdao and so
on) one month prior to admission. We initiated V-V ECMO on day 2. The
patient’s hemodynamics and infection condition improved. After detecting
of nasopharyngeal swabs and bronchoalveolar lavage samples, A/H1N1
influenza, influenza B, coronavirus, System Inflammatory Reaction
Syndrome (SIRS), Middle East respiratory syndrome (MERS) and other
epidemic disease were ruled out. On the day 22, patient’s pulmonary
images findings revealed the recover. He was transferred to a regular
room discharged soon.
CONCLUSION:The
outcome of our patient shows that V-V ECMO may also benefit the patient
when managing septic shock and septic cardiomyopathy.
KEY WORDS: Extracorporeal membrane oxygenation, sepsis, shock,
unknown
etiology pneumonia